Detalles de la búsqueda
1.
Base editing of key residues in the BCL11A-XL-specific zinc finger domains derepresses fetal globin expression.
Mol Ther
; 32(3): 663-677, 2024 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38273654
2.
Association of Type of Oral Anticoagulant Dispensed With Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for Venous Thromboembolism.
JAMA
; 327(11): 1051-1060, 2022 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35289881
3.
Comparison of a new 3-item self-reported measure of adherence to medication with pharmacy claims data in patients with cardiometabolic disease.
Am Heart J
; 228: 36-43, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32768690
4.
Cardiovascular safety of linagliptin compared with other oral glucose-lowering agents in patients with type 2 diabetes: A sequential monitoring programme in routine care.
Diabetes Obes Metab
; 21(8): 1824-1836, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30941884
5.
The relative benefits of claims and electronic health record data for predicting medication adherence trajectory.
Am Heart J
; 197: 153-162, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29447776
6.
Claims-based studies of oral glucose-lowering medications can achieve balance in critical clinical variables only observed in electronic health records.
Diabetes Obes Metab
; 20(4): 974-984, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29206336
7.
Rationale and design of the Study of a Tele-pharmacy Intervention for Chronic diseases to Improve Treatment adherence (STIC2IT): A cluster-randomized pragmatic trial.
Am Heart J
; 180: 90-7, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27659887
8.
Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn.
JAMA
; 313(21): 2142-51, 2015 Jun 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-26034955
9.
Development of a Medicare Claims-Based Model to Predict Persistent High-Dose Opioid Use After Total Knee Replacement.
Arthritis Care Res (Hoboken)
; 74(8): 1342-1348, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33450136
10.
Comparison of measures of medication adherence from pharmacy dispensing and insurer claims data.
Health Serv Res
; 57(3): 524-536, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34387355
11.
Association of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection.
JAMA Intern Med
; 180(12): 1596-1605, 2020 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32897307
12.
Prevalence and Impact of Having Multiple Barriers to Medication Adherence in Nonadherent Patients With Poorly Controlled Cardiometabolic Disease.
Am J Cardiol
; 125(3): 376-382, 2020 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31771756
13.
Safety and Effectiveness of Dabigatran and Other Direct Oral Anticoagulants Compared With Warfarin in Patients With Atrial Fibrillation.
Clin Pharmacol Ther
; 107(6): 1405-1419, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31869437
14.
Comparative Outcomes of Treatment Initiation With Brand vs. Generic Warfarin in Older Patients.
Clin Pharmacol Ther
; 107(6): 1334-1342, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31872419
15.
Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride.
Diabetes Care
; 42(12): 2204-2210, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31239281
16.
Claims Data Studies of Direct Oral Anticoagulants Can Achieve Balance in Important Clinical Parameters Only Observable in Electronic Health Records.
Clin Pharmacol Ther
; 105(4): 979-993, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30341980
17.
Evaluating utilization patterns of oral anticoagulants in routine care.
J Thromb Haemost
; 17(7): 1033-1043, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31038824
18.
Sequential Monitoring of the Comparative Effectiveness and Safety of Dabigatran in Routine Care.
Circ Cardiovasc Qual Outcomes
; 12(2): e005173, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30764655
19.
Evaluation of Socioeconomic Status Indicators for Confounding Adjustment in Observational Studies of Medication Use.
Clin Pharmacol Ther
; 105(6): 1513-1521, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30659590
20.
Preferential prescribing and utilization trends of diabetes medications among patients with renal impairment: Emerging role of linagliptin and other dipeptidyl peptidase 4 inhibitors.
Endocrinol Diabetes Metab
; 1(1): e00005, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30815542